CN114469828A - Amber congee and preparation method thereof - Google Patents
Amber congee and preparation method thereof Download PDFInfo
- Publication number
- CN114469828A CN114469828A CN202210143895.9A CN202210143895A CN114469828A CN 114469828 A CN114469828 A CN 114469828A CN 202210143895 A CN202210143895 A CN 202210143895A CN 114469828 A CN114469828 A CN 114469828A
- Authority
- CN
- China
- Prior art keywords
- phase
- parts
- extract
- amber
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 56
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 40
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 40
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 22
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 20
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 20
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 20
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 20
- 229960000458 allantoin Drugs 0.000 claims abstract description 20
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960001631 carbomer Drugs 0.000 claims abstract description 20
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 20
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 20
- 150000002148 esters Chemical class 0.000 claims abstract description 20
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 20
- 239000011734 sodium Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920002307 Dextran Polymers 0.000 claims abstract description 19
- 239000008367 deionised water Substances 0.000 claims abstract description 19
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 19
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 17
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims abstract description 17
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 15
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 15
- 239000004475 Arginine Substances 0.000 claims abstract description 14
- 241000219357 Cactaceae Species 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims abstract description 14
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940038580 oat bran Drugs 0.000 claims abstract description 14
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims abstract description 11
- 229940094944 saccharide isomerate Drugs 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims description 91
- 239000000463 material Substances 0.000 claims description 81
- 238000001816 cooling Methods 0.000 claims description 40
- 230000001804 emulsifying effect Effects 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 27
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 229920000570 polyether Polymers 0.000 claims description 12
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 238000000265 homogenisation Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000004519 grease Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 229920001213 Polysorbate 20 Polymers 0.000 abstract description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 abstract description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 abstract description 2
- 229940068977 polysorbate 20 Drugs 0.000 abstract description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 208000010668 atopic eczema Diseases 0.000 description 9
- 239000000498 cooling water Substances 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- 238000010998 test method Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses amber coagulated fat and a preparation method thereof, wherein the amber coagulated fat is prepared from the following raw materials: deionized water, dipropylene glycol, butanediol, glyceryl polyether-26, carbomer, amber powder, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin, carboxymethyl beta-dextran sodium, beta-glucan, p-hydroxyacetophenone, arginine, saccharide isomerate, cactus extract, radix ophiopogonis extract, radix scutellariae extract, oat bran extract, polysorbate-20, caprylyl hydroximic acid and essence. The amber congee prepared by adopting the special dosage for matching has better relieving and repairing effects, has good stability and is suitable for the general population.
Description
Technical Field
The invention relates to the technical field of daily cosmetics, in particular to amber congelation and a preparation method thereof.
Background
In daily life, human skin directly contacts with the external environment, and pollutants such as dust, particles, harmful gas and various bacteria exist in the air, so that the pollutants can damage the human skin (especially the facial skin) through contact, damage is caused to the skin, and skin problems such as inflammation, aging, allergy, dryness and the like are caused. The demand of Chinese people on safe and high-quality skin care products is huge, but in the skin care product industry at present, a large number of products containing antibiotics and hormones exist, and after long-term use, the skin is converted into allergic skin and is irreversible, so that the skin care products can seriously affect the daily life, work and study, and even the psychological health of people.
Therefore, a safe and reliable repair type skin care product which can relieve the skin problem, can penetrate into the skin bottom, promotes the regeneration and repair of skin tissues, reduces the recurrence is urgently needed in the market.
Disclosure of Invention
In order to solve the technical problems, the invention provides the amber grease and the preparation method thereof, and the amber powder is compounded with various plant extracts, so that the problem of skin can be relieved, and the amber powder can penetrate into the bottom of the skin to promote the regeneration and repair of skin tissues.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the invention provides amber coagulated fat which comprises the following raw materials in parts by weight:
phase A: 80-90 parts of deionized water, 2-5 parts of dipropylene glycol, 1-4 parts of butanediol, 261-3 parts of glyceryl polyether, 0.1-0.3 part of carbomer, 0.1-0.2 part of amber powder, 0.05-0.25 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.05-0.2 part of allantoin, 0.02-0.1 part of carboxymethyl beta-dextran sodium, 0.001-0.002 part of beta-glucan and 0.2-0.4 part of p-hydroxyacetophenone;
phase B: 0.1-0.5 part of arginine;
and C phase: 0.1-0.6 part of saccharide isomerate, 0.01-0.04 part of cactus extract, 0.01-0.04 part of radix ophiopogonis extract, 0.001-0.01 part of radix scutellariae extract and 0.01-0.02 part of oat bran extract;
phase D: polysorbate-200.01-0.02 parts;
phase E: 0.02-0.08 parts of caprylyl hydroximic acid;
and (3) phase F: 0.001-0.004 parts of essence.
In some specific embodiments, the amber congelation comprises the following raw materials in parts by weight:
phase A: 87.436 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.2 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
phase E: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
In some specific embodiments, the amber congelation comprises the following raw materials in parts by weight:
phase A: 87.486 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.15 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
e phase: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
In some specific embodiments, the amber congelation comprises the following raw materials in parts by weight:
phase A: 87.536 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.1 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
e phase: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
In a second aspect, the present invention provides a method for preparing the above-mentioned amber coagulated fat, comprising the following steps:
s1, adding accurately weighed deionized water into a vacuum emulsifying pot, heating to 95-100 ℃, and keeping the temperature for 30 minutes;
s2, uniformly dispersing carbomer, amber powder, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin and carboxymethyl beta-dextran sodium by using dipropylene glycol, butanediol and glyceryl polyether-26, and putting into a vacuum emulsifying pot; then, sequentially adding other materials in the phase A, and stirring the materials at a stirring speed of frequency modulation 18-20 Hz to be completely dissolved; after the materials are completely dissolved, keeping the stirring speed unchanged, keeping the temperature and stirring for 30min, and then cooling, wherein the stirring speed is frequency-modulated at 18-20 Hz;
s3, adding the B-phase material, uniformly stirring at a stirring speed of 20-25 Hz, and then cooling, wherein the stirring speed is 20-25 Hz when cooling;
s4, sequentially feeding the C-phase materials at 40-45 ℃ and uniformly stirring at a stirring speed of frequency modulation 20-25 Hz;
s5, completely dissolving the D-phase material at 40-45 ℃, adding the D-phase material, and uniformly stirring the D-phase material at a stirring speed of 20-25 Hz through frequency modulation;
s6, heating the E-phase material to 70 ℃ at 40-45 ℃, completely dissolving, cooling to 45 ℃, then adding and uniformly stirring at a frequency modulation speed of 20-25 Hz;
s7, completely dissolving the F-phase material at 40-45 ℃, then adding the F-phase material, uniformly stirring the F-phase material at a stirring speed of frequency modulation 20-25 Hz, cooling to 38 ℃ at a cooling speed of 1 ℃/min, taking the material, inspecting, stopping the machine, filtering the material after the inspection is qualified, and thus obtaining the material.
In some specific embodiments, in step S2, the homogenization rate is 2400-3000 r/min, and the homogenization time is 3 min.
In some specific embodiments, in step S2, the cooling rate is 2 deg.C/min.
In some specific embodiments, in step S3, the cooling rate is 1 deg.C/min.
In some embodiments, in step S7, the filtering operation is filtering with a 100 mesh screen.
Compared with the prior art, the invention provides the amber coagulated fat and the preparation method thereof, and the amber coagulated fat has the following beneficial effects:
in the invention, dipropylene glycol, butanediol, glyceryl polyether-26, saccharide isomerate, allantoin, radix ophiopogonis extract and arginine play a role in moisturizing; carbomer, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer plays a thickening role; the amber powder has the function of conditioning the skin; the carboxymethyl beta-glucan sodium and the beta-glucan play a role in repairing; the cactus extract has anti-allergy effect; the radix Scutellariae extract and oat bran extract have antiaging effect; the p-hydroxyacetophenone and the caprylyl hydroximic acid play a role in preserving; the polysorbate-20 plays a role in solubilization; the essence plays a role of fragrance.
The amber congee prepared by adopting the special dosage for matching has better relieving and repairing effects, has good stability and is suitable for the general population.
Detailed Description
The technical solutions of the present invention will be described clearly and completely below, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides amber coagulated fat which comprises the following raw materials in parts by weight:
phase A: 80-90 parts of deionized water, 2-5 parts of dipropylene glycol, 1-4 parts of butanediol, 261-3 parts of glyceryl polyether, 0.1-0.3 part of carbomer, 0.1-0.2 part of amber powder, 0.05-0.25 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.05-0.2 part of allantoin, 0.02-0.1 part of carboxymethyl beta-dextran sodium, 0.001-0.002 part of beta-glucan and 0.2-0.4 part of p-hydroxyacetophenone;
phase B: 0.1-0.5 part of arginine;
and C phase: 0.1-0.6 part of saccharide isomerate, 0.01-0.04 part of cactus extract, 0.01-0.04 part of radix ophiopogonis extract, 0.001-0.01 part of radix scutellariae extract and 0.01-0.02 part of oat bran extract;
phase D: polysorbate-200.01-0.02 parts;
phase E: 0.02-0.08 parts of caprylyl hydroximic acid;
and (3) phase F: 0.001-0.004 parts of essence.
The preparation method of the amber congelation comprises the following steps:
s1, adding accurately weighed deionized water into a vacuum emulsifying pot, heating to 95-100 ℃, and keeping the temperature for 30 minutes;
s2, uniformly dispersing carbomer, amber powder, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin and carboxymethyl beta-dextran sodium by using dipropylene glycol, butanediol and glyceryl polyether-26, and putting into a vacuum emulsifying pot; then, sequentially adding other materials in the phase A, and stirring the materials at a stirring speed of frequency modulation 18-20 Hz to be completely dissolved; after the materials are completely dissolved, keeping the stirring speed unchanged, keeping the temperature and stirring for 30min, and then cooling, wherein the stirring speed is frequency-modulated at 18-20 Hz;
s3, adding the B-phase material, uniformly stirring at a stirring speed of 20-25 Hz, and then cooling, wherein the stirring speed is 20-25 Hz when cooling;
s4, sequentially feeding the C-phase materials at 40-45 ℃ and uniformly stirring at a stirring speed of frequency modulation 20-25 Hz;
s5, completely dissolving the D-phase material at 40-45 ℃, adding the D-phase material, and uniformly stirring the D-phase material at a stirring speed of 20-25 Hz through frequency modulation;
s6, heating the E-phase material to 70 ℃ at 40-45 ℃, completely dissolving, cooling to 45 ℃, then adding and uniformly stirring at a frequency modulation speed of 20-25 Hz;
s7, completely dissolving the F-phase material at 40-45 ℃, then adding the F-phase material, uniformly stirring the F-phase material at a stirring speed of frequency modulation 20-25 Hz, cooling to 38 ℃ at a cooling speed of 1 ℃/min, taking the material, inspecting, stopping the machine, filtering the material after the inspection is qualified, and thus obtaining the material.
In a preferred embodiment, in step S2, the homogenization rate is 2400 to 3000r/min, and the homogenization time is 3 min.
In a preferred embodiment, in step S2, the temperature decrease rate is 2 ℃/min.
In step S3, the temperature decrease rate is preferably 1 ℃/min.
In a preferred embodiment, in step S7, the filtering operation is filtering with a 100 mesh screen.
The present invention is described in further detail below by means of detailed examples.
The starting materials used in the following examples are all commercially available.
Example 1
The embodiment provides amber coagulated fat which comprises the following raw materials in parts by weight:
phase A: 87.436 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.2 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
phase E: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
The preparation method of the amber congealing fat comprises the following steps:
s1, cleaning and disinfecting production equipment and tools, checking whether all valves of the vacuum emulsifying pot are closed, then adding accurately weighed deionized water into the vacuum emulsifying pot, heating to 95-100 ℃, and preserving heat for 30 minutes;
s2, starting a homogenizer, homogenizing and dispersing carbomer, amber powder, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin and sodium carboxymethyl beta-dextran uniformly by using dipropylene glycol, butanediol and glyceryl polyether-26, and then putting into a vacuum emulsifying pot, wherein the homogenizing rate is 2400-3000 r/min, and the homogenizing time is 3 min; then sequentially putting other materials in the phase A into a vacuum emulsifying pot, and stirring the materials at a stirring speed of frequency modulation 18-20 Hz until the materials are completely dissolved; after the materials are completely dissolved, keeping the stirring speed unchanged, keeping the temperature and stirring for 30min, and then starting cooling water to cool, wherein the cooling speed is 2 ℃/min, and the stirring speed is frequency modulated to 18-20 Hz when the temperature is lowered;
s3, putting the B-phase material into a vacuum emulsifying pot at the temperature of 60-65 ℃, uniformly stirring at the stirring speed of frequency modulation 20-25 Hz, and then starting cooling water to cool, wherein the cooling speed is 1 ℃/min, and the stirring speed is frequency modulation 20-25 Hz when cooling;
s4, sequentially putting the C-phase materials into a vacuum emulsifying pot at the temperature of 40-45 ℃, and uniformly stirring at the stirring speed of frequency modulation of 20-25 Hz;
s5, completely dissolving the D-phase material at 40-45 ℃, putting the D-phase material into a vacuum emulsifying pot, and uniformly stirring at a stirring speed of frequency modulation 20-25 Hz;
s6, heating the E-phase material to 70 ℃ at 40-45 ℃, completely dissolving, cooling to 45 ℃, putting into a vacuum emulsifying pot, and uniformly stirring at a frequency modulation speed of 20-25 Hz;
s7, completely dissolving the F-phase material at 40-45 ℃, putting the F-phase material into a vacuum emulsification pot, uniformly stirring at a frequency modulation stirring speed of 20-25 Hz, then starting cooling water, cooling to 38 ℃ at a cooling speed of 1 ℃/min, taking the material, checking, stopping the machine, and filtering and discharging by using a 100-mesh filter screen after various physicochemical indexes (viscosity, appearance, smell, PH and skin feel) are checked to be qualified.
Example 2
The embodiment provides amber coagulated fat which comprises the following raw materials in parts by weight:
phase A: 87.486 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.15 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
phase E: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
The preparation method of the amber congelation comprises the following steps:
s1, cleaning and disinfecting production equipment and tools, checking whether all valves of the vacuum emulsifying pot are closed, then adding accurately weighed deionized water into the vacuum emulsifying pot, heating to 95-100 ℃, and preserving heat for 30 minutes;
s2, starting a homogenizer, homogenizing and dispersing carbomer, amber powder, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin and sodium carboxymethyl beta-dextran uniformly by using dipropylene glycol, butanediol and glyceryl polyether-26, and then putting into a vacuum emulsifying pot, wherein the homogenizing rate is 2400-3000 r/min, and the homogenizing time is 3 min; then sequentially putting other materials in the phase A into a vacuum emulsifying pot, and stirring the materials at a stirring speed of frequency modulation 18-20 Hz until the materials are completely dissolved; after the materials are completely dissolved, keeping the stirring speed unchanged, keeping the temperature and stirring for 30min, and then starting cooling water to cool, wherein the cooling speed is 2 ℃/min, and the stirring speed is frequency modulated to 18-20 Hz when the temperature is lowered;
s3, putting the B-phase material into a vacuum emulsifying pot at the temperature of 60-65 ℃, uniformly stirring at the stirring speed of frequency modulation 20-25 Hz, and then starting cooling water to cool, wherein the cooling speed is 1 ℃/min, and the stirring speed is frequency modulation 20-25 Hz when cooling;
s4, sequentially putting the C-phase materials into a vacuum emulsifying pot at the temperature of 40-45 ℃, and uniformly stirring at the stirring speed of frequency modulation of 20-25 Hz;
s5, completely dissolving the D-phase material at 40-45 ℃, putting the D-phase material into a vacuum emulsifying pot, and uniformly stirring at a stirring speed of frequency modulation 20-25 Hz;
s6, heating the E-phase material to 70 ℃ at 40-45 ℃, completely dissolving, cooling to 45 ℃, putting into a vacuum emulsifying pot, and uniformly stirring at a stirring speed of frequency modulation 20-25 Hz;
s7, completely dissolving the F-phase material at 40-45 ℃, putting the F-phase material into a vacuum emulsification pot, uniformly stirring at a frequency modulation stirring speed of 20-25 Hz, then starting cooling water, cooling to 38 ℃ at a cooling speed of 1 ℃/min, taking the material, checking, stopping the machine, and filtering and discharging by using a 100-mesh filter screen after various physicochemical indexes (viscosity, appearance, smell, PH and skin feel) are checked to be qualified.
Example 3
The embodiment provides amber coagulated fat which comprises the following raw materials in parts by weight:
phase A: 87.536 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.1 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
phase E: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
The preparation method of the amber congelation comprises the following steps:
s1, cleaning and disinfecting production equipment and tools, checking whether all valves of the vacuum emulsifying pot are closed, then adding accurately weighed deionized water into the vacuum emulsifying pot, heating to 95-100 ℃, and preserving heat for 30 minutes;
s2, starting a homogenizer, homogenizing and dispersing carbomer, amber powder, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin and sodium carboxymethyl beta-dextran uniformly by using dipropylene glycol, butanediol and glyceryl polyether-26, and then putting into a vacuum emulsifying pot, wherein the homogenizing rate is 2400-3000 r/min, and the homogenizing time is 3 min; then sequentially putting other materials in the phase A into a vacuum emulsifying pot, and stirring the materials at a stirring speed of frequency modulation 18-20 Hz until the materials are completely dissolved; after the materials are completely dissolved, keeping the stirring speed unchanged, keeping the temperature and stirring for 30min, and then starting cooling water to cool, wherein the cooling speed is 2 ℃/min, and the stirring speed is frequency modulated to 18-20 Hz when the temperature is lowered;
s3, putting the B-phase material into a vacuum emulsifying pot at the temperature of 60-65 ℃, uniformly stirring at the stirring speed of frequency modulation 20-25 Hz, and then starting cooling water to cool, wherein the cooling speed is 1 ℃/min, and the stirring speed is frequency modulation 20-25 Hz when cooling;
s4, sequentially putting the C-phase materials into a vacuum emulsifying pot at the temperature of 40-45 ℃, and uniformly stirring at the stirring speed of frequency modulation of 20-25 Hz;
s5, completely dissolving the D-phase material at 40-45 ℃, putting the D-phase material into a vacuum emulsifying pot, and uniformly stirring at a stirring speed of frequency modulation 20-25 Hz;
s6, heating the E-phase material to 70 ℃ at 40-45 ℃, completely dissolving, cooling to 45 ℃, putting into a vacuum emulsifying pot, and uniformly stirring at a frequency modulation speed of 20-25 Hz;
s7, completely dissolving the F-phase material at 40-45 ℃, putting the F-phase material into a vacuum emulsification pot, uniformly stirring at a frequency modulation stirring speed of 20-25 Hz, then starting cooling water, cooling to 38 ℃ at a cooling speed of 1 ℃/min, taking the material, checking, stopping the machine, and filtering and discharging by using a 100-mesh filter screen after various physicochemical indexes (viscosity, appearance, smell, PH and skin feel) are checked to be qualified.
To verify the beneficial effects of the present invention, the following tests were performed.
First, stability test
30g of the amber congealed fat prepared in examples 1 to 3 were respectively put into 30ml PET bottles, 3 bottles were respectively put in an environment of room temperature, heat resistance (48 + -1) DEG C and cold resistance (-18 + -2) DEG C for 1D, 3D, 1W, 2W, 1M, 3M, 5M and 6M, and the state of the product was observed and evaluated, and the test results are shown in Table 1.
Table 1 product stability test results
As can be seen from the results of Table 1 above, the amber congeal prepared by the present invention has good stability.
Second, testing the usage effect
50 subjects with dry skin and eczema (except for subjects with healthy body) were tested for the effects of moisturizing, moisture retention, allergic reaction, etc. using the amber congee prepared in examples 1-3, wherein 40 adult women and 10 infants within 3 years old were used. The results are shown in Table 2.
The moistening test method comprises the following steps: the efficacy was evaluated after 0.5 hour of smearing on the inner side of the arm, behind the ear, and on the face of the subject.
Moisture retention test method: efficacy was evaluated after applying to the inner arm, behind the ear, and on the face of the subject for 8 hours.
Allergic reaction test method: the test subjects were applied to the inner side of the arm, behind the ear and on the face, and heat sensation evaluation was performed after 1 hour, itching evaluation was performed after 8 hours, and erythema evaluation was performed after 24 hours.
Skin dryness recovery test method: the skin drying part of the subject is smeared once every 8 hours, and the skin drying recovery evaluation is carried out after 48 hours.
Eczema recovery test method: the test piece is smeared on the skin eczema part of a test subject once every 8 hours, and the recovery evaluation of the skin eczema is carried out after the test piece is continuously used for 7 days.
The eczema recurrence test method comprises the following steps: smearing on the skin eczema part of a subject once every 8 hours, continuously using for 7 days, stopping using for 7 days, and evaluating the recurrence of the skin eczema.
TABLE 2 comparison table for use effect test in examples 1 to 3
The results of the usage effect test in table 2 show that: the amber gel meets the technical standard requirements of products, the product efficacy test meets the product regulation requirements, and the product meets the regulation requirements of cosmetic safety technical specification (2015 edition), and the amber gel can help the skin to eliminate inflammation symptoms such as red swelling, pain and itch caused by dryness, strengthen the skin, supplement a sebum membrane, moisten the skin, promote the regeneration of skin tissues, reduce the recurrence of eczema, and has good effect of relieving and repairing.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (9)
1. The amber coagulated fat is characterized by comprising the following raw materials in parts by weight:
phase A: 80-90 parts of deionized water, 2-5 parts of dipropylene glycol, 1-4 parts of butanediol, 261-3 parts of glyceryl polyether, 0.1-0.3 part of carbomer, 0.1-0.2 part of amber powder, 0.05-0.25 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.05-0.2 part of allantoin, 0.02-0.1 part of carboxymethyl beta-dextran sodium, 0.001-0.002 part of beta-glucan and 0.2-0.4 part of p-hydroxyacetophenone;
phase B: 0.1-0.5 part of arginine;
and C phase: 0.1-0.6 part of saccharide isomerate, 0.01-0.04 part of cactus extract, 0.01-0.04 part of radix ophiopogonis extract, 0.001-0.01 part of radix scutellariae extract and 0.01-0.02 part of oat bran extract;
phase D: polysorbate-200.01-0.02 parts;
phase E: 0.02-0.08 parts of caprylyl hydroximic acid;
and (3) phase F: 0.001-0.004 parts of essence.
2. The amber grease as claimed in claim 1, which is prepared from the following raw materials in parts by weight:
phase A: 87.436 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.2 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: 200.0167 parts of polysorbate-water;
phase E: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
3. The amber grease as claimed in claim 1, which is prepared from the following raw materials in parts by weight:
phase A: 87.486 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.15 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
phase E: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
4. The amber grease as claimed in claim 1, which is prepared from the following raw materials in parts by weight:
phase A: 87.536 parts of deionized water, 5 parts of dipropylene glycol, 3 parts of butanediol, 262.5 parts of glycerol polyether, 0.2 part of carbomer, 0.1 part of amber powder, 0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 part of allantoin, 0.05 part of carboxymethyl beta-dextran sodium, 0.002 part of beta-glucan and 0.4 part of p-hydroxyacetophenone;
phase B: 0.35 part of arginine;
and C phase: 0.5 part of saccharide isomer, 0.01 part of cactus extract, 0.015 part of radix ophiopogonis extract, 0.002 part of radix scutellariae extract and 0.015 part of oat bran extract;
phase D: polysorbate-200.0167 parts;
phase E: 0.05 part of caprylyl hydroximic acid;
and (3) phase F: 0.0033 parts of essence.
5. The method for producing amber curds according to any one of claims 1 to 4, comprising the following steps:
s1, adding accurately weighed deionized water into a vacuum emulsifying pot, heating to 95-100 ℃, and keeping the temperature for 30 minutes;
s2, uniformly dispersing carbomer, amber powder, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin and carboxymethyl beta-dextran sodium by using dipropylene glycol, butanediol and glyceryl polyether-26, and putting into a vacuum emulsifying pot; then, sequentially adding other materials in the phase A, and stirring the materials at a stirring speed of frequency modulation 18-20 Hz to be completely dissolved; after the materials are completely dissolved, keeping the stirring speed unchanged, keeping the temperature and stirring for 30min, and then cooling, wherein the stirring speed is frequency-modulated at 18-20 Hz;
s3, adding the B-phase material, uniformly stirring at a stirring speed of 20-25 Hz, and then cooling, wherein the stirring speed is 20-25 Hz when cooling;
s4, sequentially feeding the C-phase materials at 40-45 ℃ and uniformly stirring at a stirring speed of frequency modulation 20-25 Hz;
s5, completely dissolving the D-phase material at 40-45 ℃, adding the D-phase material, and uniformly stirring the D-phase material at a stirring speed of 20-25 Hz through frequency modulation;
s6, heating the E-phase material to 70 ℃ at 40-45 ℃, completely dissolving, cooling to 45 ℃, then adding and uniformly stirring at a frequency modulation speed of 20-25 Hz;
s7, completely dissolving the F-phase material at 40-45 ℃, then adding the F-phase material, uniformly stirring the F-phase material at a stirring speed of frequency modulation 20-25 Hz, cooling to 38 ℃ at a cooling speed of 1 ℃/min, taking the material, inspecting, stopping the machine, filtering the material after the inspection is qualified, and thus obtaining the material.
6. The method of claim 5, wherein: in step S2, the homogenization rate is 2400-3000 r/min, and the homogenization time is 3 min.
7. The method of claim 1, wherein: in step S2, the cooling rate is 2 ℃/min.
8. The method of claim 1, wherein: in step S3, the cooling rate is 1 deg.C/min.
9. The method of claim 1, wherein: in step S7, the filtering operation is filtering with a 100 mesh screen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210143895.9A CN114469828A (en) | 2022-02-17 | 2022-02-17 | Amber congee and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210143895.9A CN114469828A (en) | 2022-02-17 | 2022-02-17 | Amber congee and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114469828A true CN114469828A (en) | 2022-05-13 |
Family
ID=81481968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210143895.9A Pending CN114469828A (en) | 2022-02-17 | 2022-02-17 | Amber congee and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114469828A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114796076A (en) * | 2022-05-13 | 2022-07-29 | 南京益唯森生物科技有限公司 | An anti-allergy composition containing Scutellariae radix extract and its preparation method |
| CN114796076B (en) * | 2022-05-13 | 2024-06-04 | 南京益唯森生物科技有限公司 | Antiallergic composition containing radix Scutellariae extract and its preparation method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107913216A (en) * | 2017-11-17 | 2018-04-17 | 广州今盛美精细化工有限公司 | A kind of cactus is releived moisturizing emulsion and preparation method thereof |
-
2022
- 2022-02-17 CN CN202210143895.9A patent/CN114469828A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107913216A (en) * | 2017-11-17 | 2018-04-17 | 广州今盛美精细化工有限公司 | A kind of cactus is releived moisturizing emulsion and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 广州合众无纺化妆品集团有限公司: "魅妍肌琥珀凝脂露" * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114796076A (en) * | 2022-05-13 | 2022-07-29 | 南京益唯森生物科技有限公司 | An anti-allergy composition containing Scutellariae radix extract and its preparation method |
| CN114796076B (en) * | 2022-05-13 | 2024-06-04 | 南京益唯森生物科技有限公司 | Antiallergic composition containing radix Scutellariae extract and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108338965B (en) | Coarse grain composition and preparation method thereof | |
| CN110772463B (en) | Eye skin repair composition and preparation method and application thereof | |
| CN111249187A (en) | Wrinkle-removing eye cream and preparation method thereof | |
| CN111920746B (en) | Moisturizing and repairing mask and preparation method thereof | |
| CN111557886B (en) | Plant-nourishing efficient moisturizing cream and preparation method thereof | |
| CN110433113A (en) | A kind of essence dew and preparation method containing the anti-ageing composition of moisturizing | |
| CN113081904A (en) | Long-acting moisturizing antioxidant essence and preparation process thereof | |
| CN112137951A (en) | Silicone-oil-free transparent amino acid shampoo capable of strengthening hair and repairing scalp barrier and preparation method thereof | |
| CN112754956A (en) | Formula and preparation method of cactus polysaccharide anti-inflammatory moisturizing mask | |
| CN114796050A (en) | Efficient moisturizing and relieving gel mask and preparation method thereof | |
| CN107115347B (en) | Liposome antiallergic agent and cosmetic for repairing hormone-dependent dermatitis | |
| CN114259453A (en) | Sensitive muscle relieving and repairing spray and preparation method and application thereof | |
| CN114306165A (en) | Moisturizing composition and preparation method thereof | |
| CN108379197B (en) | Skin barrier repairing and moisturizing mask and preparation method thereof | |
| CN112263528A (en) | Collagen jelly mask and preparation and use methods thereof | |
| CN114469828A (en) | Amber congee and preparation method thereof | |
| CN111265442A (en) | Skin care composition and application thereof | |
| CN110876686A (en) | Repairing composition and preparation method thereof | |
| CN113318062B (en) | Skin barrier repairing composition, skin barrier repairing liquid and preparation method thereof | |
| CN113081924B (en) | Antioxidant composition, preparation method and application | |
| CN114748396A (en) | Soothing and moisturizing composition suitable for desert muscles and preparation method and application thereof | |
| CN115089533A (en) | Moisturizing and relieving essence and preparation method thereof | |
| CN113559016A (en) | Amino acid shampoo capable of relieving and relieving itching for dry scalp | |
| CN109199955B (en) | Water replenishing spray and preparation method thereof | |
| CN108619018B (en) | Skin barrier repair cream and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220513 |
|
| RJ01 | Rejection of invention patent application after publication |